Drug intelligence / Profile preview

Lianju Ganmao Capsule

Development stage: Unknown
Lead developer: Tasly Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Lianju Ganmao Capsule is a Chinese patent medicine formulated as a combination of traditional Chinese medicinal ingredients. It is primarily indicated for the treatment of the common cold, specifically targeting symptoms associated with wind-heat syndrome, such as fever, headache, fatigue, nasal congestion, sneezing, sore throat, and cough. The drug's mechanism of action, rooted in Traditional Chinese Medicine (TCM) principles, involves dispelling wind-heat, removing toxicity, soothing the throat, clearing heat, and purging the lungs through its various herbal and mineral components. It has been investigated in clinical trials to evaluate its efficacy and safety for these indications.

Brand names: Lianju Ganmao capsule
Other names: LJGMC莲菊感冒胶囊

Beyond the preview

Go deeper on Lianju Ganmao Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lianju Ganmao Capsule.

Explore the full profile